Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.

<h4>Background</h4>Information on how well Isoniazid Preventive Therapy (IPT) works on reducing TB incidence among people living with HIV (PLHIV) in routine settings using robust statistical methods to establish causality in observational studies is scarce.<h4>Objectives</h4>...

Full description

Bibliographic Details
Main Authors: Werner M Maokola, Bernard J Ngowi, Michael J Mahande, Jim Todd, Masanja Robert, Sia E Msuya
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0254082
_version_ 1818400828447260672
author Werner M Maokola
Bernard J Ngowi
Michael J Mahande
Jim Todd
Masanja Robert
Sia E Msuya
author_facet Werner M Maokola
Bernard J Ngowi
Michael J Mahande
Jim Todd
Masanja Robert
Sia E Msuya
author_sort Werner M Maokola
collection DOAJ
description <h4>Background</h4>Information on how well Isoniazid Preventive Therapy (IPT) works on reducing TB incidence among people living with HIV (PLHIV) in routine settings using robust statistical methods to establish causality in observational studies is scarce.<h4>Objectives</h4>To evaluate the effectiveness of IPT in routine clinical settings by comparing TB incidence between IPT and non-IPT groups.<h4>Methods</h4>We used data from PLHIV enrolled in 315 HIV care and treatment clinic from January 2012 to December 2016. We used Inverse Probability of Treatment Weighting to adjust for the probability of receiving IPT; balancing the baseline covariates between IPT and non-IPT groups. The effectiveness of IPT on TB incidence was estimated using Cox regression using the weighted sample.<h4>Results</h4>Of 171,743 PLHIV enrolled in the clinics over the five years, 10,326 (6.01%) were excluded leaving 161,417 available for the analysis. Of the 24,800 who received IPT, 1.00% developed TB disease whereas of the 136,617 who never received IPT 6,085 (4.98%) developed TB disease. In 278,545.90 person-years of follow up, a total 7,052 new TB cases were diagnosed. Using the weighted sample, the overall TB incidence was 11.57 (95% CI: 11.09-12.07) per 1,000 person-years. The TB incidence among PLHIV who received IPT was 10.49 (95% CI: 9.11-12.15) per 1,000 person-years and 12.00 (95% CI: 11.69-12.33) per 1,000 person-years in those who never received IPT. After adjusting for other covariates there was 52% lower risk of developing TB disease among those who received IPT compared to those who never received IPT: aHR = 0.48 (95% CI: 0.40-0.58, P<0.001).<h4>Conclusion</h4>IPT reduced TB incidence by 52% in PLHIV attending routine CTC in Tanzania. IPTW adjusted the groups for imbalances in the covariates associated with receiving IPT to achieve comparable groups of IPT and non-IPT. This study has added evidence on the effectiveness of IPT in routine clinical settings and on the use of IPTW to determine impact of interventions in observational studies.
first_indexed 2024-12-14T07:42:47Z
format Article
id doaj.art-d29ec6fb9e4b4a88bd94db67f90a882c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T07:42:47Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d29ec6fb9e4b4a88bd94db67f90a882c2022-12-21T23:10:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01167e025408210.1371/journal.pone.0254082Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.Werner M MaokolaBernard J NgowiMichael J MahandeJim ToddMasanja RobertSia E Msuya<h4>Background</h4>Information on how well Isoniazid Preventive Therapy (IPT) works on reducing TB incidence among people living with HIV (PLHIV) in routine settings using robust statistical methods to establish causality in observational studies is scarce.<h4>Objectives</h4>To evaluate the effectiveness of IPT in routine clinical settings by comparing TB incidence between IPT and non-IPT groups.<h4>Methods</h4>We used data from PLHIV enrolled in 315 HIV care and treatment clinic from January 2012 to December 2016. We used Inverse Probability of Treatment Weighting to adjust for the probability of receiving IPT; balancing the baseline covariates between IPT and non-IPT groups. The effectiveness of IPT on TB incidence was estimated using Cox regression using the weighted sample.<h4>Results</h4>Of 171,743 PLHIV enrolled in the clinics over the five years, 10,326 (6.01%) were excluded leaving 161,417 available for the analysis. Of the 24,800 who received IPT, 1.00% developed TB disease whereas of the 136,617 who never received IPT 6,085 (4.98%) developed TB disease. In 278,545.90 person-years of follow up, a total 7,052 new TB cases were diagnosed. Using the weighted sample, the overall TB incidence was 11.57 (95% CI: 11.09-12.07) per 1,000 person-years. The TB incidence among PLHIV who received IPT was 10.49 (95% CI: 9.11-12.15) per 1,000 person-years and 12.00 (95% CI: 11.69-12.33) per 1,000 person-years in those who never received IPT. After adjusting for other covariates there was 52% lower risk of developing TB disease among those who received IPT compared to those who never received IPT: aHR = 0.48 (95% CI: 0.40-0.58, P<0.001).<h4>Conclusion</h4>IPT reduced TB incidence by 52% in PLHIV attending routine CTC in Tanzania. IPTW adjusted the groups for imbalances in the covariates associated with receiving IPT to achieve comparable groups of IPT and non-IPT. This study has added evidence on the effectiveness of IPT in routine clinical settings and on the use of IPTW to determine impact of interventions in observational studies.https://doi.org/10.1371/journal.pone.0254082
spellingShingle Werner M Maokola
Bernard J Ngowi
Michael J Mahande
Jim Todd
Masanja Robert
Sia E Msuya
Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
PLoS ONE
title Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
title_full Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
title_fullStr Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
title_full_unstemmed Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
title_short Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
title_sort impact of isoniazid preventive therapy on tuberculosis incidence among people living with hiv a secondary data analysis using inverse probability weighting of individuals attending hiv care and treatment clinics in tanzania
url https://doi.org/10.1371/journal.pone.0254082
work_keys_str_mv AT wernermmaokola impactofisoniazidpreventivetherapyontuberculosisincidenceamongpeoplelivingwithhivasecondarydataanalysisusinginverseprobabilityweightingofindividualsattendinghivcareandtreatmentclinicsintanzania
AT bernardjngowi impactofisoniazidpreventivetherapyontuberculosisincidenceamongpeoplelivingwithhivasecondarydataanalysisusinginverseprobabilityweightingofindividualsattendinghivcareandtreatmentclinicsintanzania
AT michaeljmahande impactofisoniazidpreventivetherapyontuberculosisincidenceamongpeoplelivingwithhivasecondarydataanalysisusinginverseprobabilityweightingofindividualsattendinghivcareandtreatmentclinicsintanzania
AT jimtodd impactofisoniazidpreventivetherapyontuberculosisincidenceamongpeoplelivingwithhivasecondarydataanalysisusinginverseprobabilityweightingofindividualsattendinghivcareandtreatmentclinicsintanzania
AT masanjarobert impactofisoniazidpreventivetherapyontuberculosisincidenceamongpeoplelivingwithhivasecondarydataanalysisusinginverseprobabilityweightingofindividualsattendinghivcareandtreatmentclinicsintanzania
AT siaemsuya impactofisoniazidpreventivetherapyontuberculosisincidenceamongpeoplelivingwithhivasecondarydataanalysisusinginverseprobabilityweightingofindividualsattendinghivcareandtreatmentclinicsintanzania